Skip to main content

Series A Biopharma Companies

Explore 108 biopharma startups that raised series a funding. Access verified founder contact information and fundraising data.

Total Companies
108
Total Funding
$694.4M
Avg Funding
$27.8M
Cities
21

Export 108 Series A Biopharma Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
San Diego, United States
$180.0M
raised

Timberlyne Therapeutics is a biopharmaceutical company that develops therapies for autoimmune diseases.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

$955K
raised

RadioNano Therapeutics is a medical technology company that develops radiation therapy solutions for the treatment of cancer patients.

Dec 2024
Series A

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$3.0M
raised

Gabaeron is a biopharmaceutical business that develops therapeutics for neurological illnesses based on stem cells and small chemicals.

Dec 2024
Series A

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark
$23.8M
raised

Unlocking home medication with pharma grade storage compliance as a service

Dec 2024
Series A

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark
$11.7M
raised

Hervolution Therapeutics develops immunotherapies targeting tumors using Human Endogenous Retroviral proteins (HERVs).

Dec 2024
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 108 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$52.0M
raised

Tasca is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.

Dec 2024
Series A

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$13.4M
raised

LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy

Sep 2024
Series A

Founder Contacts

41,000+ verified contacts

Orleans, France
$7.2M
raised

Overseed is an biotechnology based company which does R&D process on cannabis production for pharmaceutical purposes.

Jul 2024
Series A

Founder Contacts

41,000+ verified contacts

Nelson, New Zealand
$8.7M
raised

Broad-spectrum antiviral drug development

Jun 2024
Series A

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$26.0M
raised

Nabla Bio is an autoverse platform of proprietary biologically informed machine learning that co-develops antibody drugs.

May 2024
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 108 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Birmingham, United States
$7.0M
raised

Acclinate leverages sustained engagement and AI-driven insights to empower communities to take actions for better health.

May 2024
Series A

Founder Contacts

41,000+ verified contacts

Geneva, Switzerland
$63.0M
raised

Neurosterix is a biopharmaceutical firm dedicated to creating allosteric modulators for the treatment of neurological illnesses.

Apr 2024
Series A

Founder Contacts

41,000+ verified contacts

San Leandro, United States
$11.4M
raised

Tierra Biosciences is a synthetic biology company that offers an AI-driven platform with a vast range of custom proteins for research.

Mar 2024
Series A

Founder Contacts

41,000+ verified contacts

La Jolla, United States
$85.0M
raised

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

Oct 2023
Series A

Founder Contacts

41,000+ verified contacts

Rue Du Rosult, France
$10.7M
raised

Stane's objective is to mobilize collective wisdom to improve community medicine's performance.

Sep 2023
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 108 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Mount Laurel, United States
$25.0M
raised

CCM Biosciences operates as a biopharmaceutical company.

Aug 2023
Series A

Founder Contacts

41,000+ verified contacts

Dijon, France
$8.7M
raised

Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs.

Jun 2023
Series A

Founder Contacts

41,000+ verified contacts

Olathe, United States
$6.5M
raised

Ronawk develops a T-Block technology producing patient-specific biologics to treat diseases, cancer, organ injuries, and burns.

May 2023
Series A

Founder Contacts

41,000+ verified contacts

Boston, United States
$20.0M
raised

Alloplex Biotherapeutics develops a cellular therapeutic platform for treating cancer.

Feb 2023
Series A

Founder Contacts

41,000+ verified contacts

Solna, Sweden
$18.4M
raised

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 108 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Francisco, United States
$57.0M
raised

Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.

Jan 2024
Series A

Founder Contacts

41,000+ verified contacts

Houston, United States
$17.0M
raised

Pranax is a biotechnology company that develops and commercializes regenerative medicine solutions centered on exosome technology.

Jan 2026
Series A

Founder Contacts

41,000+ verified contacts

Chicago, United States
$20.0M
raised

Prenosis develops data-driven diagnostic tools and precision medicine solutions for acute care conditions.

Jan 2026
Series A

Founder Contacts

41,000+ verified contacts

San Diego, United States
$12.0M
raised

Bloom Science is a clinical-stage central nervous system company developing novel therapeutics for patients with neurological disorders.

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

Mclean, United States
$6.0M
raised

KeifeRx is a biotech company focused on the discovery of disease-modifying treatments for neurodegenerative illnesses.

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

Showing 51 to 75 of 108 companies

Ready to Connect with Series A Biopharma Startups?

Get verified founder emails, funding details, and company data for 108 series a biopharma companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked